Research and experimental development on natural sciences and engineering
KLYV THERAPEUTICS AS
Revenue 2024
NOK 935,000
Operating profit
NOK 161,000
Equity
NOK 718,000
Incorporated
2023
Share capital
NOK 122,000
Roles
Daglig lederMaria Vistnes
Regnskapsfører
Styrets lederAndreas Berg
StyremedlemMaria Vistnes
StyremedlemTorkild Stenbock
StyremedlemBeret Luise Sundet
Shareholders
| Name | Stake | Shares | Year |
|---|---|---|---|
| SPRINGHEART HOLDING AS | 77.5% | 80635.000000 | 2025 |
| TAILORMADE INVEST AS | 19.8% | 20635.000000 | 2025 |
| PRECO AS | 1.4% | 1465.000000 | 2025 |
| BERET LUISE SUNDET | 0.6% | 644.000000 | 2025 |
| ALEFA AS | 0.6% | 644.000000 | 2025 |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.